| | | | | | | | | | | | | | | | | | | | | | |
Ownership Document
|
| Schema Version: X0306 |
| Document Type: 4 |
| Period of Report: 3/4/22 |
| Not Subject to Section 16: 0 |
| Issuer: |
| Issuer CIK: 1606498 |
| Issuer Name: AVANOS MEDICAL, INC. |
| Issuer Trading Symbol: AVNS |
| Reporting Owner: |
| Reporting Owner ID: |
| | Owner CIK: 1775747 |
| | Owner Name: Ball David Edward |
| Reporting Owner Address: |
| | Owner Street 1: 5405 WINDWARD PKWY |
| | Owner Street 2: |
| | Owner City: ALPHARETTA |
| | Owner State: GA |
| | Owner ZIP Code: 30004 |
| | Owner State Description: |
| Reporting Owner Relationship: |
| | Is Director? No |
| | Is Officer? Yes |
| | Is Ten Percent Owner? No |
| | Is Other? No |
| | Officer Title: SVP - Global Supply Chain |
| | Other Text: |
| Non-Derivative Table: |
| Non-Derivative Transaction: |
| | Security Title: |
| | | Value: Common Stock |
| | Transaction Date: |
| | | Value: 3/4/22 |
| | Transaction Coding: |
| | | Transaction Form Type: 4 |
| | | Transaction Code: A |
| | | Equity Swap Involved? No |
| | Transaction Amounts: |
| | | Transaction Shares: |
| Value: 11,241 |
| Footnote ID: F1 |
| | | Transaction Price Per Share: |
| Value: 0 |
| | | Transaction Acquired-Disposed Code: |
| Value: A |
| | Post-Transaction Amounts: |
| | | Shares Owned Following Transaction: |
| Value: 27,569 |
| Footnote ID: F2 |
| | Ownership Nature: |
| | | Direct or Indirect Ownership: |
| Value: D |
| Derivative Table: |
| Footnotes: |
| Footnote - F1: Represents time-based restricted share units awarded pursuant to the Issuer's 2021 Long Term Incentive Plan. The award will vest 1/3 on March 4, 2023, 1/3 on March 4, 2024 and 1/3 on March 4, 2025. |
| Footnote - F2: Includes 4,728 shares which were reported on a Form 4 filed on May 6, 2019, but which were inadvertently omitted from subsequently filed Form 4s. |
| Remarks: |
| Owner Signature: |
| Signature Name: /s/ Mojirade James, as attorney-in-fact for David E. Ball |
| Signature Date: 3/8/22 |
